Sustabol 350 mg is an oil-based testosterone blend injectable manufactured by British Dragon and dosed at 350 mg/mL in a 10 mL vial. It combines four testosterone esters — propionate, isocaproate, phenylpropionate, and decanoate — in a single formulation.
Sustabol 350 mg contains a four-ester testosterone blend designed to provide both rapid and extended release of testosterone after administration. The inclusion of short-acting testosterone propionate alongside longer-acting esters such as testosterone decanoate allows for a more immediate onset of action while maintaining elevated testosterone levels between injections.
In clinical practice, testosterone replacement therapy is used for appropriately diagnosed hypogonadism, a condition characterized by consistently low testosterone concentrations alongside compatible symptoms. The Endocrine Society emphasizes that diagnosis requires accurate measurement of testosterone levels and that symptoms alone are not sufficient for diagnosis. In non-medical bodybuilding settings, multi-ester testosterone blends are commonly referenced as a base compound for bulking or mass-building cycles because of their ability to deliver both fast and sustained testosterone exposure.
The different esters in Sustabol 350 mg are metabolized at different rates, which is intended to produce more stable blood levels than a single-ester preparation. Testosterone itself supports muscle protein synthesis, recovery, strength, and maintenance of male physiological characteristics. When used at supraphysiologic levels for physique enhancement, however, the potential for adverse effects increases and such use falls outside approved medical indications.
Sustabol 350 mg uses MCT oil as its carrier oil, providing the oil base for the four-ester testosterone blend.
The four-ester formulation of Sustabol 350 mg is designed to combine the pharmacokinetic characteristics of short-, medium-, and long-acting testosterone esters into a single injectable preparation.
Each ester in Sustabol 350 mg influences how quickly testosterone is released from the injection site. Testosterone propionate is a short-acting ester with a reported half-life of approximately 1 to 2 days, contributing to a rapid increase in serum testosterone after injection. Testosterone phenylpropionate and isocaproate occupy an intermediate position, while testosterone decanoate is a long-acting ester with a reported half-life of approximately 21 days, supporting prolonged elevation of testosterone levels.
The rationale for blending these esters is to provide an initial surge of testosterone from the short-acting component followed by sustained release from the longer-acting components. This design is intended to reduce the frequency of injections compared to using a short-acting ester alone, while still providing a more rapid onset than a single long-acting ester.
Once the esters are metabolized, the active hormone in all cases is testosterone itself. The ester primarily determines the rate of release and duration of activity rather than changing the underlying anabolic and androgenic properties of testosterone.
Sustabol 350 mg is designed to provide both a rapid initial increase in testosterone and a prolonged elevation between injections. The propionate ester contributes to the faster component, while the decanoate ester supports the extended-release component. This multi-ester design distinguishes it from single-ester testosterone preparations such as testosterone cypionate or enanthate.
British Dragon offers several testosterone formulations built around different esters and concentrations. The main practical distinction between these preparations is the rate and duration of testosterone release after administration.
Sustabol 350 mg is a multi-ester blend, whereas Testabol Depot (testosterone cypionate) and Testabol Enanthate are single-ester long-acting preparations. A shorter-acting single-ester option is Testabol Propionate. The higher concentration of Sustabol 350 mg compared to these alternatives means that a smaller injection volume delivers a higher total testosterone dose.
The information below is provided for educational reference only. Testosterone is a prescription androgen; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
In medically supervised testosterone replacement therapy, dosing is individualized based on laboratory results, symptom response, and the specific product used. The Endocrine Society notes that testosterone therapy should aim to achieve levels in the mid-normal range. In non-medical bodybuilding settings, multi-ester testosterone blends such as Sustabol 350 mg are commonly referenced in the range of 350–700 mg per week, with the higher end of this range generally associated with experienced users. Because the propionate ester is short-acting, injection frequency of at least twice weekly is commonly referenced to take advantage of the fast-acting component.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| TRT (medical) | Individualized by clinician | Per clinical protocol |
| Bodybuilding (non-medical, beginner) | 350–525 mg / week | 2–3 times weekly |
| Bodybuilding (non-medical, experienced) | 525–700 mg / week | Every other day or 3x weekly |
In non-medical bodybuilding contexts, multi-ester testosterone is frequently used as a base compound and may be combined with other injectable or oral compounds. British Dragon offers several products commonly referenced in this context, including Decabol 250 for bulking and Stanabol 10 during cutting phases.
Because Sustabol 350 mg contains fast-acting esters, injection frequency should be considered carefully. More frequent injections are generally referenced to maintain stable blood levels and minimize fluctuations associated with the propionate component.
Testosterone aromatizes to estrogen, which can contribute to water retention, gynecomastia, and elevated blood pressure in susceptible individuals. Aromatase inhibitors such as Anastrozole are commonly referenced in this context, though use should be based on individual response and bloodwork where possible.
Cholesterol and hematocrit levels should be monitored during testosterone use, as testosterone can affect lipid profiles and increase red blood cell production.
After completing a cycle with Sustabol 350 mg, post-cycle therapy is commonly recommended in bodybuilding contexts to help restore endogenous testosterone production. Agents such as Clomiphene and Tamoxifen are commonly referenced for this purpose.
PCT protocols vary based on cycle length, compounds used, and individual factors. Bloodwork can help inform recovery strategy.
Dosing strategies, support compounds, and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Testosterone is a prescription androgen that can affect hormonal, reproductive, cardiovascular, and hematologic function. Medical testosterone therapy requires appropriate diagnosis, clinical supervision, and ongoing monitoring.
Testosterone replacement therapy is intended for appropriately diagnosed testosterone deficiency. The Endocrine Society emphasizes that diagnosis requires both compatible symptoms and consistently low testosterone concentrations measured accurately, rather than symptoms alone.
Use of testosterone at supraphysiologic levels for bodybuilding or performance enhancement falls outside approved replacement therapy and can increase exposure to androgen-related adverse effects.
Higher-than-physiologic testosterone exposure can carry additional health risks. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Testosterone therapy can increase red blood cell production and hematocrit. Excessive elevation can require medical evaluation and changes to treatment. Monitoring may also include blood pressure, prostate-related assessment, and evaluation for other treatment-related adverse effects.
Testosterone can suppress the body's own reproductive hormone signaling and reduce sperm production. Fertility is therefore an important consideration, particularly for men planning to have children. The Endocrine Society has raised concerns about the impact of testosterone therapy on fertility recovery.
Other potential androgen-related effects can include acne, changes in skin oil production, fluid retention, and changes in prostate-related symptoms. Individual response and risk vary according to health status, exposure, and other factors.
Testosterone therapy is not appropriate for everyone. Medical guidelines identify circumstances in which treatment should be avoided or carefully evaluated, including known or suspected prostate or male breast cancer, elevated hematocrit, untreated severe obstructive sleep apnea, certain cardiovascular conditions, thrombophilia, and near-term fertility plans.
Existing cardiovascular disease, urinary or prostate symptoms, abnormal blood counts, and other medical conditions should be discussed with a qualified healthcare professional before testosterone therapy is considered.
Medically supervised testosterone therapy typically involves follow-up assessment to evaluate treatment response, adverse effects, and relevant laboratory markers. Depending on the individual, monitoring may include testosterone concentrations, hematocrit, and prostate-related evaluation.
The Endocrine Society recommends screening and monitoring if testosterone therapy is initiated, noting that long-term safety including prostate cancer risk remains incompletely established.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated, or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Sustabol 350 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Sustabol 350 mg product, use the security features on the vial label and cross-check them with official British Dragon presentation. Genuine British Dragon vials typically feature specific label characteristics and packaging details that distinguish them from counterfeits.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oil-based formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Sustabol 350 mg, the four-ester testosterone blend, usage, and related topics.
Sustabol 350 mg contains a four-ester testosterone blend. In medical practice, testosterone is used for appropriately diagnosed testosterone deficiency (hypogonadism). In non-medical bodybuilding settings, multi-ester testosterone blends are commonly referenced as a base compound for muscle growth and strength, though such use falls outside approved medical indications.
Because Sustabol 350 mg contains testosterone propionate, a short-acting ester, injection frequency of at least twice weekly is commonly referenced to take advantage of the fast-acting component. In bodybuilding contexts, every-other-day or three-times-weekly administration is sometimes preferred to maintain stable blood levels.
Testosterone can suppress endogenous testosterone production. In non-medical bodybuilding contexts, post-cycle therapy is commonly referenced after a cycle to support hormonal recovery. Agents such as Clomiphene and Tamoxifen are commonly discussed for this purpose.
The four testosterone esters in Sustabol 350 mg release testosterone at different rates after injection. The propionate ester acts quickly, while the decanoate ester provides a slower, more sustained release. The active hormone in all cases is testosterone, which supports muscle protein synthesis, recovery, and male physiological function.
The propionate component of Sustabol 350 mg is released relatively quickly after injection, with a reported half-life of approximately 1 to 2 days. The longer-acting esters provide sustained release over a longer period. Visible effects on physique and performance are typically referenced as taking several weeks to become apparent, depending on dose, diet, training, and individual factors.
There is no single testosterone preparation that is universally best. Multi-ester blends such as Sustabol 350 mg are designed to provide both rapid and extended release, while single-ester preparations offer more predictable release characteristics. The appropriate formulation depends on the circumstances in which testosterone is being used.
Sustabol 350 mg is a four-ester blend, while Testabol Depot is a single-ester testosterone cypionate preparation. The blend is designed to provide both fast and slow release of testosterone, whereas cypionate provides a more gradual and prolonged release from a single ester.
Sustabol 350 mg contains testosterone propionate as one of its four esters, along with longer-acting esters. Testabol Propionate contains only the short-acting propionate ester. The blend provides both rapid and extended release, while the propionate-only product has a shorter duration of activity and requires more frequent injections.
A milligram amount cannot be classified as appropriate or excessive without considering the medical indication, individual response, laboratory results, and treatment schedule. In bodybuilding contexts, 350 mg per week falls within commonly referenced ranges, but this does not establish that it is safe or appropriate for any individual. Non-medical use falls outside approved indications.
Sustabol 350 mg is labeled at 350 mg of total testosterone esters per mL, comprising testosterone propionate 42 mg, testosterone isocaproate 84 mg, testosterone phenylpropionate 84 mg, and testosterone decanoate 140 mg. It is supplied in a 10 mL vial, giving 3,500 mg of total labeled testosterone content per vial.
Yes. Testosterone aromatizes to estrogen, and this applies to all testosterone esters in Sustabol 350 mg. This can contribute to water retention, gynecomastia, and elevated blood pressure in susceptible individuals. Aromatase inhibitors are commonly referenced in this context, though use should be based on individual response and bloodwork where possible.